Description
Added on the 26/02/2021 14:55:26 - Copyright : France 24 EN
Researchers working to develop a vaccine against COVID-19 must consider a few things. The inevitable mutation of the virus is one of the most important considerations, says UPI. They must also monitor its evolution to ensure that inoculations continue to prevent infection. New vaccines could become available as early as later this year. Researchers should use virus samples collected during testing to check for new strains. New strains could mean that the virus may not respond to the vaccine formulation.
Americans need to be prepared for the possibility that they may feel a little unwell. After you get a coronavirus vaccine, if one is authorized, you may experience some negative side effects. The CDC met to discuss whether to recommend the use of any Covid-19 vaccines. The US Food and Drug Administration or FDA is the agency that might authorize one. Volunteers in vaccine trials have reported they frequently feel flu-like effects after getting vaccinated. This could affect people's willingness to get vaccinated in the first place.
New Jersey announced Thursday it would start vaccinating people age 65 and older. But also, they will be vaccinating people with underlying health conditions against the coronavirus. One of those health conditions that now bumps New Jerseyans to the front of the line is smoking. Only people age 75 and older and essential workers were recommended to be next in line. However, US officials recently urged states to expand eligibility says Business Insider. Smoking makes it much harder for your lungs to be healthy, putting you at risk for COVID.
The US Department of Health and Human Services expanded COVID-19 vaccine availability. The agency said they will now include people age 65 and older in the initial phase of distribution. According to UPI, the changes also give priority to those with underlying health conditions. People of any age with underlying health conditions are at higher risk for serious illness from COVID-19 infection. In addition to expanding the priority population, HHS will also be releasing the nation's "entire supply" of vaccines. As of Tuesday, just 9 million of the 25 million vaccine doses distributed had been administered.
|
Support : Technical 
- Content 
- Editors 
